Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589926 · ClinicalTrials.gov registry record · NA
Bi-Level Positive Airway Ventilation for Acute Chest Syndrome
A NA study, sponsored by Albert Einstein College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01589926 is a NA study that was terminated before completion, run by Albert Einstein College of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT01589926, a NA study, was terminated before completion, sponsored by Albert Einstein College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Acute chest syndrome (ACS) is a frequent complication of sickle cell disease and is diagnosed by having findings on a chest x-ray and one of the following: chest pain, fever, or trouble breathing. Patients with Acute Chest Syndrome can get very sick and require an exchange transfusion (special large blood transfusion) and mechanical ventilation. Bi-level Positive Airway Pressure (also known as BLPAP or BiPAP) is a device that blows air into a patients lungs via a mask that covers the nose. The goal of this study is to determine whether giving children BiPAP when they have ACS, in addition to providing standard clinical care for ACS, alters the clinical course of these patients. The investigators hypothesize that patients receiving effective BiPAP will have milder clinical courses resulting in shorter hospital stays and fewer transfers to the intensive care unit and exchange transfusions.
Interventions
- DEVICE Sham CPAP
- DEVICE Bi-level positive airway pressure device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01589926
The ClinicalTrials.gov registry entry for NCT01589926 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham CPAP is the first listed.
NCT01589926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01589926 about?
NCT01589926 is a clinical study titled "Bi-Level Positive Airway Ventilation for Acute Chest Syndrome". Acute chest syndrome (ACS) is a frequent complication of sickle cell disease and is diagnosed by having findings on a chest x-ray and one of the following: chest pain, fever, or trouble breathing. Patients with Acute Chest Syndrome can get very sick and require an exchange transfusion (special large...
What is the current status of trial NCT01589926?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2012-07. Estimated completion is 2016-09-08.
What interventions are being tested in trial NCT01589926?
The interventions under investigation include: Sham CPAP (DEVICE), Bi-level positive airway pressure device (DEVICE).
Who is sponsoring clinical trial NCT01589926?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.